Abstract
There have been rare reports of glomerulopathies developing in patients with Bartter syndrome (BS) and its milder variant, Gitelman syndrome (GS). We present the first case of C1q nephropathy (C1qN) in an African American child with GS. This child was diagnosed with GS at 9 years of age and subsequently developed nephrotic range proteinuria 3 years later. Renal biopsy revealed mesangial hypercellularity and focal segmental glomerulosclerosis (FSGS). The segmental lesions were generally located at the vascular pole. Dominant C1q (2+) staining along with IgG (1–2+) was demonstrated in the mesangium, which correlated with scattered electron dense mesangial deposits demonstrated by electron microscopy. Treatment with an angiotensin-converting enzyme inhibitor led to an improvement in proteinuria to near-normal values (urine protein/creatinine ratio down to 0.5), but the creatinine clearance declined to approximately 58 ml/min/1.73 m2. This case highlights the possible association between the milder hypokalemic tubulopathy, GS, and glomerular disease, including C1qN. Prompt evaluation of proteinuria with renal biopsy in these patients is recommended to detect significant glomerular pathology. Further research is needed to define risk factors for this complication.

References
Su IH, Frank R, Gauthier BG, Valderrama E, Simon DB, Lifton RP, Trachtman H (2000) Bartter syndrome and focal segmental glomerulosclerosis: a possible link between two diseases. Pediatr Nephrol 14:970–972
Calò LA, Marchini F, Davis PA, Rigotti P, Pagnin E, Semplicini A (2003) Kidney transplant in Gitelman’s syndrome. Report of the first case. J Nephrol 16:144–147
Bonfante L, Davis PA, Spinello M, Antonello A, D’Angelo AD, Semplicini A, Calo L (2001) Chronic renal failure, end-stage renal disease, and peritoneal dialysis in Gitelman’s syndrome. Am J Kidney Dis 38:165–168
Bulucu F, Vural A, Yenicesu M, Caglar K (1998) Association of Gitelman’s syndrome and focal glomerulosclerosis. Nephron 79:244
Blethen SL, Van Wyck JJ, Lorentz WB, Jennette JC (1985) Reversal of Bartter’s syndrome by renal transplantation in a child with focal, segmental glomerular sclerosis. Am J Med Sci 289:31–36
Sardani Y, Qin K, Haas M, Aronson AJ, Rosenfield RL (2003) Bartter syndrome complicated by immune complex nephropathy. Case report and literature review. Pediatr Nephrol 18:913–918
Cortesi C, Foglia PEG, Bettinelli A, Bianchetti MG (2003) Prevention of cardiac arrhythmias in pediatric patients with normotensive-hypokalemic tubulopathy. Current attitude among European pediatricians. Pediatr Nephrol 18:729–730
Pachulski RT, Lopez F, Sharaf R (2005) Gitelman’s not-so-benign syndrome. New Engl J Med 353:850–851
Cruz DN, Shaer AJ, Bia MJ, Lifton RP, Simon DB (2001) Gitelman’s syndrome revisited: an evaluation of symptoms and health-related quality of life. Kidney Int 59:710–717
Doi T, Kanatsu K, Suehiro F, Nagai H, Yoshida H, Hamashima Y (1987) Clinicopathological study of patients with mesangial isolated C3d deposition in various glomerular diseases. Nephron 46:188–193
Cannon PJ, Leeming JM, Sommers SC, Winters RW, Laragh JH (1968) Juxtaglomerular cell hyperplasia and secondary hyperaldosteronism (Bartter’s syndrome): a re-evaluation of the pathophysiology. Medicine (Baltimore) 47:107–131
Rudin A (1988) Bartter’s syndrome. A review of 28 patients followed for 10 years. Acta Med Scand 224:165–171
Fogo AB (2001) Progression and potential regression of glomerulosclerosis. Kidney Int 59:804–819
Wolf G, Butzmann U, Wenzel UO (2003) The renin-angiotensin system and progression of renal disease: from hemodynamics to cell biology. Nephron Physiol 93:3–13
Seikaly MG, Arant BS Jr, Seney FD Jr (1990) Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat. J Clin Invest 86:1352–1357
Jennette JC, Hipp CG (1985) C1q nephropathy: a distinct pathologic entity usually causing nephrotic syndrome. Am J Kidney Dis 6:103–110
Jennette JC, Falk RJ (2001) C1q nephrology. In: Massry SG, Glassock RJ (eds) Massry and Glassock’s textbook of nephrology, 4th edn. Lippincott, Williams & Wilkins, Philadelphia, Pennsylvania, pp 730–733
Markowitz GS, Schwimmer JA, Stokes MB, Nasr S, Seigle RL, Valeri AM, D’Agati VD (2003) C1q nephropathy: a variant of focal segmental glomerulosclerosis. Kidney Int 64:1232–1240
Shappell SB, Myrthil G, Fogo A (1997) An adolescent with relapsing nephrotic syndrome: minimal-change disease versus focal-segmental glomerulosclerosis versus C1q nephropathy. Am J Kidney Dis 29:966–970
Iskandar SS, Browning MC, Lorentz WB (1991) C1q nephropathy: a pediatric clinicopathologic study. Am J Kidney Dis 18:459–465
Lau KK, Gaber LW, Santo NM, Wyatt RJ (2005) C1q nephropathy: features at presentation and outcome. Pediatr Nephrol 20:744–749
Kersnik Levart T, Kenda RB, Cavic MA, Ferlung D, Hvala A, Vizjak A (2005) C1q nephropathy in children. Pediatr Nephrol 20:1756–1761
Guay-Woodford LM (1998) Bartter syndrome: unraveling the pathophysiologic enigma. Am J Med 105:151–161
Schurman SJ, Perlman SA, Sutphen R, Campos A, Garin EH, Cruz DN, Shoemaker LR (2001) Genotype/phenotype observations in African Americans with Bartter syndrome. J Pediatr 139:105–110
Suthanthiran M, Khanna A, Cukran D, Adhikarla R, Sharma VK, Singh T, August P (1998) Transforming growth factor-β1 hyperexpression in African American end-stage renal disease patients. Kidney Int 53:639–644
Zelikovic I (2003) Hypokalaemic salt-losing tubulopathies: an evolving story. Nephrol Dial Transplant 18:1696–1700
Zelikovic I, Szargel R, Hawash A, Labay V, Hatib I, Cohen N, Nakhoul F (2003) A novel mutation in the chloride channel gene, CLCNKB, as a cause of Gitelman and Bartter syndromes. Kidney Int 63:24–32
Jeck N, Konrad M, Peters M, Weber S, Bonzel KE, Seyberth HW (2000) Mutations in the chloride channel gene, CLCNKB, leading to a mixed Bartter-Gitelman phenotype. Pediatr Res 48:754–758
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hanevold, C., Mian, A. & Dalton, R. C1q nephropathy in association with Gitelman syndrome: a case report. Pediatr Nephrol 21, 1904–1908 (2006). https://doi.org/10.1007/s00467-006-0261-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-006-0261-9